Mylan has launched its generic version of GlaxoSmithKline’s respiratory blockbuster, Advair, at a 70% discount compared with the original drug. Cheaper competition to off-patent Advair has been ...

GSK has said it does not believe generic competition to Advair will arrive in the US this year, but has conceded it is a possibility, and this would place another £1.5 million-worth of sales at risk.

Company has Koshal & Associates as its auditors. As on 30-09-2024, the company has a total of 55.37 Crore shares outstanding.Generic Pharmasec Share Price Today is Rs. 3.11 as on 06 Jan, 2025, 03:56 ...